AnticoagEvaluator vs MCSAID

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for patients with cardiogenic shock. A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the common devices used for hemodynamic support in unstable patients. There is an algorithm for helping understand the decision process depending on key clinical variables such as cardiac output and PAPI. There are also several weaning and escalation algorithm. A calculator section is available for some common hemodynamic variables used in MCS decision-making and is available for quick-reference throughout the algorithm. MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.